A Phase 3 Study Assesing Subject Perception of Treatment Burden Using Weekly Versus Daily Injection

Clinical Trial

Offered by: Nemours Children's Specialty Care
Location: Jacksonville and Pensacola in Florida

Trial Name

A Phase 3 Study Assesing Subject Perception of Treatment Burden Using Weekly Versus Daily Injection

What is the trial about?

The purpose of this research study is to compare the treatment experience of a weekly Somatrogon injection schedule and a daily Genotropin® (somatropin) injection schedule.

Who can participate?

Children with who have either isolated Growth Hormone Deficiency (GHD) or Growth Hormone insufficiency and are ages 3 to under 18.

What is involved?

Your child will be in this research study for about 24 weeks. Your child will need to visit the research site at least 6 times during the study and you will be called at least 3 times during the study.

There are 3 blood draws during this study.

Contact Nemours Clinical Trials

Trial Name: A Phase 3 Study Assesing Subject Perception of Treatment Burden Using Weekly Versus Daily Injection

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org